Lower GI 2017

3. HDR-EBT – Boost after EBRT

Late results (published in 2014) - No benefit on late outcome (OS, PFS, LC, distant mets) - Improved tumor regression does not lead to relevant clinical benefit when high- quality surgery is performed

Appelt et al. Int J Radiat Oncol Biol Phys. 2014;90(1):110–8.